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Abstract Type Three Secretion Systems (T3SSs) are
essential virulence determinants of many Gram-negative
bacteria. The T3SS is an injection device that can transfer
bacterial virulence proteins directly into host cells. The
apparatus is made up of a basal body that spans both
bacterial membranes and an extracellular needle that pos-
sesses a channel that is thought to act as a conduit for
protein secretion. Contact with a host-cell membrane trig-
gers the insertion of a pore into the target membrane, and
effectors are translocated through this pore into the host
cell. To assemble a functional T3SS, speciﬁc substrates
must be targeted to the apparatus in the correct order.
Recently, there have been many developments in our
structural and functional understanding of the proteins
involved in the regulation of secretion. Here we review the
current understanding of protein components of the system
thought to be involved in switching between different
stages of secretion.
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Introduction
Many Gram-negative bacterial pathogens use Type Three
Secretion Systems (T3SSs) to inject bacterial virulence
proteins directly into eukaryotic host target cells. T3SSs are
complex macromolecular machines that consist of the
structural components of the apparatus itself, secreted
proteins (including pore-forming translocators and effec-
tors), chaperones and cytoplasmic regulators. The
apparatus is made up of a basal body that spans both
bacterial membranes and an extracellular needle that pro-
trudes from the bacterial surface. The basal body possesses
rotational symmetry and is made up of several rings of
integral membrane and periplasmic proteins (reviewed in
[1, 2]). During morphogenesis, the components of the
transmembrane rings are handled by the Sec machinery
while subsequent components are sequentially exported by
the T3S apparatus itself [3, 4]. The needle projects from the
basal body and is assembled by the polymerization of a
single, small needle subunit (reviewed in [5, 6]). Both the
basal body and needle are hollow, containing a channel that
is thought to act as a conduit for protein secretion [7, 8].
The needle terminates in a tip structure made of several
copies of the tip protein (reviewed in [5, 6, 9]). Upon
contact with a host-cell membrane, the T3SS exports two
distinct categories of proteins: the translocators that form a
pore in the target membrane and the effectors that trafﬁc
through this pore into the host cell.
In order to build a functional T3SS, there are distinct
stages during assembly that have speciﬁc requirements
regarding the substrates to be exported and the timing of
the switch to the next stage. These stages are brieﬂy out-
lined below and illustrated in Fig. 1. Early substrates such
as the proteins that make up the rod (the periplasmic por-
tion of the needle that lies within the basal body) and
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membrane rings are formed (Fig. 1a) [3]. This stage must
be monitored as it is known that the length of the needle is
well controlled [10–12]. Thus, the substrate speciﬁcity of
the apparatus must be switched at the appropriate point to
arrest needle growth (Fig. 1b) [13]. The trigger for this
switch involves a component of the inner membrane and an
early substrate of the export apparatus, a cytoplasmic
protein known as the length-control protein [14, 15]. Fol-
lowing completion of the needle structure, the tip proteins
are exported, and secretion must be blocked until contact
with a host-cell membrane (Fig. 1c) [16]. This block is
mediated in part by a cytoplasmic protein that is thought to
act as a gatekeeper and that may be able to respond to
speciﬁc signals following host-cell contact [17–20]. Upon
contact, translocators must be secreted and inserted into the
host cell membrane to form a pore prior to secretion of late
substrates, the effectors (Fig. 1d) [21, 22]. In this way,
effectors will be exported directly into host cells rather than
into the extracellular milieu.
Clearly, pathogens require several mechanisms to ensure
hierarchical and temporal control over the secretion of
T3SS components. Regulation of secretion is controlled at
several levels: transcriptional, post-transcriptional, trans-
lational as well as via the conformational switching and
secretion of T3SS components (reviewed in [23, 24]). In
this review, we will address the most recent work relating
to the protein components of the system thought to be
involved in the switching between different stages of
assembly and secretion. Component names from repre-
sentative families are provided in Table 1. Although there
are signiﬁcant homologies between pathogenic T3SS
and ﬂagellar secretion, especially in the early stages of
assembly, we will not include a detailed discussion of
ﬂagella components in this review as this has been covered
by other recent reviews [25–27].
The secretion apparatus: components and targeting
Reconstructions of the basal body reveal the presence of a
socket structure within the inner membrane ring [28, 29].
This structure is visible from the cytoplasmic face of the
basal body and extends into the hollow chamber of the
T3SS basal body. The socket is thought to act as an anchor
for the inner rod that traverses the length of the basal body
and connects to the extracellular needle. Although the
proteins that make up the socket structure have not been
identiﬁed, it is likely to be formed by at least some of the
domains of the ﬁve well-conserved inner membrane pro-
teins that are associated with the basal body. In Shigella
these are: Spa9, Spa29, Spa24, Spa40 and MxiA (Table 1).
The roles these inner membrane proteins may play in
export are not well understood. However, two of these
components (Spa40 and MxiA) possess cytoplasmic
domains [30–32] that are likely to be accessible to cyto-
plasmic proteins such as the secretion substrates, their
chaperone-complexes and cytoplasmic regulators.
As protein production and secretion are not always cou-
pled, some T3SS proteins must be stored in the bacterial
cytoplasm in a secretion-competent state, but blocked from
interacting prematurely with partner proteins or the appa-
ratus itself. Specialised chaperones play this role by
reversibly binding one or several partner proteins. Several
different classes of chaperones can be distinguished based
on structural and functional analysis as reviewed in[33–36].
Recognition and targeting of proteins to the T3S appa-
ratus requires that secreted proteins possess a secretion
signal. Several studies have identiﬁed a signal in the
N-terminus of effector proteins either encoded in the
mRNA [37, 38] or the peptide sequence [39–42]. Recently,
several groups have used machine learning techniques to
identify cryptic secretion signals within the protein
sequence of the N-terminus of T3SS effector proteins
[43–45]. Although these studies indicate that most secreted
Fig. 1 Schematic diagram illustrating different secretion states of
pathogenic Type Three Secretion Systems. a Following assembly of
the basal body (black outline) into the inner and outer bacterial
membranes (grey), early substrates including the needle subunit
(black oval) and the needle-length control protein (black star) are
targeted to the apparatus for secretion. b The secreted needle subunits
assemble to form a hollow extracellular needle. Upon completion of
the needle, the secretion apparatus undergoes the ﬁrst substrate
speciﬁcity switch to secrete the tip proteins. c Tip proteins (black
squares) are secreted and assemble at the tip of the needle, and further
secretion is blocked until host-cell contact. d Host-cell contact
triggers the second switch at which point the pore-forming translo-
cator proteins are inserted into the host-cell membrane, and effector
proteins (black hexagons) are targeted to the host cell
1066 J. E. Deane et al.substrates possess a protein-encoded secretion signal, they
do not preclude the role of mRNA as some effectors are
surprisingly tolerant to frameshift mutations [44]. The
secretion signals of early substrates appear to be different
from that of the effectors. In Pseudomonas syringae,
N-terminal truncations of the needle-length control protein,
HrpP, were still translocated, suggesting this substrate
possesses an atypical secretion signal [46]. In Yersinia,i t
has been shown that the needle-length control protein
possesses two independent secretion signals, only one of
which is at the N-terminus [47]. In addition, studies of the
Yersinia tip protein reveal that an N-terminal His tag does
not block secretion and that the C-terminus is also required
for export, suggesting that the signal sequences differ
between early and late substrates. However, there is cur-
rently very little data available on the speciﬁc targeting of
early substrates to the T3S apparatus.
The ﬁrst switch: needle length control via substrate
speciﬁcity switching
The substrate speciﬁcity switch from early substrates
(needle and rod subunits) to later substrates must only
occur once the needle has reached its full length. This is
important since the length of the needle must match
speciﬁc structures at the bacterial and host-cell surfaces
[48, 49]. Needle length varies between species, but is well
controlled within species: *50 nm in Shigella, *60 nm in
Yersinia enterocolitica and *55 nm in SPI-1 of Salmo-
nella [10–12, 21, 50]. At its simplest, length control
involves two steps: the measurement of needle length and
the switch of substrate speciﬁcity, i.e., halting the secretion
of needle subunits. The needle-length control proteins are
located in the same region of their respective genomes, but
they possess very little sequence identity, and large regions
are predicted to be highly unstructured. Knockout muta-
tions of Spa32 in Shigella, InvJ in Salmonella or YscP in
Yersinia lead to abnormally long needles and defects in
effector secretion [10–13, 15, 51–54].
Several recent reviews have discussed in detail the dif-
ferent models for needle-length control in T3SS and
ﬂagella [55–58] as well as the homology of these control
mechanisms to those used by bacteriophage-tail and ﬂa-
gella-hook length control [55]. For this reason, we will
restrict this discussion to the data and models relevant to
understanding the most recent work done in this ﬁeld.
Needle length: the ruler/tape-measure model
In Yersinia, insertions and deletions were engineered into
the yscP sequence and the length of needles measured [10].
Table 1 Equivalences between representative families for components mentioned in the text (adapted from [87])
Shigella ﬂexneri Escherichia coli LEE Yersinia sp. Salmonella sp. SPI-1
Early substrates
Needle subunit MxiH EscF YscF PrgI
Rod subunit MxiI EscI YscI PrgJ
Length-control Spa32 Orf16
a YscP InvJ
Middle substrates
Tip IpaD EspA
b LcrV SipD
Pore IpaB/C EspD/B YopB/D SipB/C
Secretion apparatus components
Inner-membrane Spa9 EscS YscS SpaQ
Inner-membrane Spa29 EscT YscT SpaR
Inner-membrane Spa24 EscR YscR SpaP
Inner-membrane MxiA EscV YscV InvA
Switch Spa40 EscU YscU SpaS
ATPase Spa47 EscN YscN InvC
ATPase-associated MxiN EscL YscL OrgB
ATPase-associated MxiK Orf4 YscK OrgA
ATPase-associated Spa33 EscQ YscQ SpaO
Regulator/gatekeeper MxiC SepL YopN/TyeA InvE
a Based on its position within the type III secretion gene cluster and its predicted secondary structure, Pallen et al. identify Orf16 as a candidate
for the needle-length control protein [87]
b The Escherichia coli extension to the basal body is very different from that of other T3SS as it possesses an additional ﬁlament structure
beyond the needle. Thus, the polymerization of EspA is quite different from that of the other tip proteins (reviewed in [5])
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number of residues of YscP and the mean needle length,
suggesting that the extended protein might act as a
molecular ruler. Mutation of the secretion signals of YscP
reduces or abolishes its secretion, and length control is
dramatically impaired [47]. This result suggests that the
export of YscP is coupled to its measuring activity, leading
to the proposal that YscP may measure needle length
directly. This model proposes that YscP would function as
an extended polypeptide anchored to the tip of the growing
needle and the base of the needle complex. Its full exten-
sion would signal that the needle has reached the
appropriate length. A recent paper by Wagner et al. has
shown that in Yersinia, the needle length changed in
inverse function of the helical content, indicating that not
only the number of residues but also their structure controls
length [59]. These data support the ruler model and indi-
cate that the functional ruler in this system possesses some
helical structure. In some species the needle-length control
protein is much shorter than in Yersinia, for example,
Spa32 from Shigella possesses only 292 residues compared
with 515 residues for YscP. As the Shigella needle is only
*15% shorter than in Yersinia, this suggests that Spa32
would possess almost no helical content while measuring
the needle length. Future studies altering the amount of
helical content in different members of this family will
help establish the importance of secondary structure in
determining needle length across species.
This model for needle-length control implies that the
length-control protein is either present in the needle
channel while needle subunits are being secreted or that it
can be secreted without triggering the substrate switch.
This latter model was originally proposed in the ﬂagella
ﬁeld and was named the ‘‘infrequent export’’ model [60]. In
this model, the needle length-control protein is periodically
secreted during needle assembly to ‘‘check’’ whether the
needle has reached full length. This would require that the
mechanism by which it signals completion of the needle
must not be prematurely triggered (see the substrate switch
section below). The possible mechanisms by which this
may work remain unclear. Alternatively, if the length-
control protein remains in the needle channel, there must
be sufﬁcient room to ﬁt both the ruler protein and the
needle subunits being secreted. Several different methods
have been used to estimate the diameter of the bore of
the needle. The electron microscopy reconstruction of the
Shigella needle resulted in a bore of 2.5 nm [61]. The
modelling of the needle assembly within this reconstruc-
tion using the X-ray structure of the needle subunit from
Shigella gave a bore size of 1.8 nm [62]. This difference is
likely due to the uncertainties inherent in each method, for
example, the relatively low resolution of the reconstruction
and the ambiguity in positioning of the helices lining the
needle channel [61, 62]. Since a folded a-helix (including
side chains) has a diameter of *1.2 nm, the question of
whether one or two folded helices can simultaneously ﬁt in
the needle channel remains uncertain. If the ruler remains
in the needle channel during assembly, the narrower bore
size would require the complete unfolding of either the
ruler or the needle subunit protein. If the ruler protein is
unfolded, then the secondary structure content becomes
irrelevant in the measurement, and so the results of Wagner
et al. require that the needle subunit be completely
unfolded.
Recent work in Shigella has shown that large deletions
within spa32 do not produce shorter needles than those
generated by variations with minimal deletions [14]. Fur-
thermore, Spa32 variants lacking internal residues 37–94 or
130–159 retained full Spa32 function indicating that, in
Shigella, control of needle length is not via a YscP-like
molecular ruler mechanism. Botteaux et al. also showed
that Spa32 and InvJ or YscP are functionally inter-
changeable (including needle-length control and
translocator secretion) despite very different protein sizes.
In contrast, insertion of just the YscP ruler domain into
Spa32 produced longer needles, supporting the role of
YscP as a molecular ruler [10, 14]. As discussed previously
this may be subtly affected by the proportion of helical
content in these proteins, but does suggest that the mea-
suring function may be subtly different between species
and that the current ruler/tape-measure models may be
oversimpliﬁed.
Substrate speciﬁcity switching: the Spa32-like proteins
Despite the low sequence homology of the needle-length
control proteins, a small domain near the C-terminus of
these proteins was identiﬁed by hydrophobic cluster anal-
ysis and named the type III secretion substrate speciﬁcity
switch (T3S4) domain [63]. This domain is predicted
to possess a globular structure, an ab-fold and a Pro-
x-Leu-Gly signature. In Yersinia, the over-expression of
this domain in strains lacking yscP restores secretion of
effectors, but needle length remains variable, suggesting
the T3S4 domain plays a role in the substrate switch.
Together with the results discussed above, this suggests
that this family of proteins may be bifunctional: they
determine needle length and trigger the substrate switch.
Substrate speciﬁcity switching: the Spa40-like proteins
The switch of substrate speciﬁcity is also controlled by one
of the inner membrane components of the system, the
highly conserved Spa40 family [55, 58, 64, 65]. These
proteins possess a cytoplasmic domain that has been shown
to undergo an autocatalytic cleavage event to produce a
1068 J. E. Deane et al.small C-terminal domain that remains tightly associated
with the membrane-bound N-terminal fragment. Cleavage
occurs between the Asn and Pro within the highly con-
served Asn-Pro-Thr-His (NPTH) sequence within the
cytoplasmic domain. Mutants of the N and P prevent
cleavage and interfere with the substrate switch. Non-
cleavable mutants in Salmonella SpaS and E. coli EPEC
EscU block secretion of translocators and ﬁlament com-
ponents [64]. Similarly, mutation of the N or P to alanine
(N263A or P264A) in the Yersinia homologue YscU results
in bacteria that do not export the tip protein or translocators
(LcrV, YopB and YopD) [65]. These non-cleaving mutants
do form needles, although longer and less controlled than
the wild type, and are capable of secreting late effectors
[65]. In the YscU N263A mutant strain, export of the tip
protein can be restored if a hybrid protein is constructed
that possesses at its N-terminus the signal sequence from
an effector protein (residues 1–15 of YopE) [65]. This
implies that the tip/translocators have a speciﬁc type of
export signal and a status distinct from the late effectors
regarding export. This led to the proposal that YscU
cleavage is required to adopt the conformation allowing
recognition of the translocators.
In the last year several structures have been determined
for the cytoplasmic domain of proteins belonging to this
family: EscUC of E. coli,S p a S C of Salmonella, Spa40C of
Shigella and YscUC of Yersinia [64, 66–68] (Fig. 2). These
structures revealed that the NPTH sequence lies on a sur-
face-exposed loop and is cleaved in the absence of any
other factors (Fig. 2, main panel). Structures of cleaved and
uncleavable mutants of these proteins reveal that there is a
distinct conformation for this loop in each state and that the
cleaved loop is stabilised by surrounding residues (Fig. 2,
bottom inset). Analysis of the uncleavable mutants sug-
gests that the protein fold presents the loop in a
conformation that is primed for the cleavage event to
occur. It has therefore been proposed that cleavage occurs
immediately upon folding and that the switching event is a
consequence of partner proteins interacting with the
cleaved protein. In artiﬁcial systems where the cleavage
event is blocked by mutation, the surface properties of the
protein are altered and thus may not present the necessary
structure for substrate switching rather than the structure of
the uncleaved form playing an active role in inhibiting the
switch. If, as has been proposed in the ﬂagella ﬁeld,
cleavage of this loop acts as a trigger for substrate
switching, then the timing of this cleavage event becomes
critical, and these proteins must be maintained in an
uncleavable state until the needle is completed. Such a state
could be attained by the speciﬁc chemistry of the protein
fold itself, or by external factors such as pH or inhibitory
proteins. It should be noted that in wild-type Y. entero-
colitica with YscU expressed at natural levels, the cleavage
at the NPTH site was not complete, i.e., full length unc-
leaved protein was detected in puriﬁed membranes [65].
This is therefore an area that requires further investigation.
The structures also revealed that the N-terminal portion
of the cytoplasmic domain is able to adopt very different
conformations (Fig. 2, top inset). This ﬂexibility may be
due to different crystallisation conditions or may be the
result of separating this domain from the membrane-bound
portion of the protein. It is also possible that this region is
genuinely ﬂexible and that the position of this domain
within the secretion apparatus may play a role in regula-
tion. As shown previously for ﬂagella, deletions or point
mutations in this region of EscU abolish secretion of both
translocators and effectors [64, 69]. This suggests a distinct
role for this region in the export capability of the apparatus
rather than its substrate speciﬁcity. Further experiments are
required to address this question, including a structure of
the intact, full-length protein including the N-terminal
integral membrane region.
Fig. 2 Structures of the cytoplasmic domain of the substrate
speciﬁcity switch protein. Main panel: Ribbon diagram of Shigella
ﬂexneri Spa40C illustrating the N-(green) and C-(magenta) terminal
regions of this domain (PDB: 2VT1). Left panel: Overlay of the
NPTH-loop region from cleaved and non-cleavable mutants of EscU,
SpaS, Spa40 and YscU (PDB: 3BZL, 3BZP, 3BZY, 3C01, 2VT1,
2V5G, 2JLJ, 2JLI). Top panel: Views of the N-terminal regions of
EscU, Spa40 and YscU overlaid via the C-terminal region to illustrate
the lack of deﬁned structure at the N-terminus (PDB: 3BZL, 3BZV,
2VT1, 2V5G)
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In addition to lack of translocator export, the YscU
N263A mutant exported reduced amounts of YscP and
made longer needles [65]. Overexpression of yscP in the
N263A strain resulted in increased export of YscP,
resulting in needles of normal length, but did not restore
translocator secretion. Therefore, failure in needle length
control of the N263A mutant was due to the failure of
YscP export rather than the failure to switch substrate
speciﬁcity. Furthermore, the recovery of needle-length
control indicates that the N263A mutation does not affect
the capacity of the T3S export apparatus to switch off the
export of needle subunits. Since the uncleavable variant
of YscU can give rise to different needle lengths
depending on the amount of YscP exported, this supports
the hypothesis that the cleavage event itself is not the
trigger.
Much work has been done in the ﬂagella ﬁeld looking
at the interplay between the hook-length control protein,
FliK, and the substrate switching protein, FlhB (reviewed
in [57, 58]). Speciﬁc mutations within the cytoplasmic
domain of FlhB were identiﬁed that rescue the ﬂiK null
mutant [70, 71]. Equivalent mutations were made in
Yersinia YscU and were shown to restore effector secre-
tion (i.e. are capable of switching) in yscP null mutants
[15]. These data suggest that YscU and YscP work
together to control both needle length and switch the
substrate speciﬁcity of the secretion apparatus. Recently,
Botteaux et al. have identiﬁed a direct interaction between
the cytoplasmic domain of Spa40 and a short C-terminal
region within the predicted T3S4 domain of Spa32 [14].
Removal of these residues from Spa32 resulted in a non-
functional protein suggesting that the interaction with
Spa40 is crucial for the switch from early to later
substrates.
Recent work from Riordan et al. has identiﬁed inter-
actions between YscU and ATPase-regulator complexes.
When puriﬁed from the cytoplasm of Yersinia, cleaved
YscUC bound to YscL/K/Q but lacked interaction with
YscN or YscP or LcrV [72]. It was also shown that
overexpression of any yscU allele (including wild-type)
abolished type III secretion, suggesting that YscU may
bind and sequester an essential component of the appa-
ratus [72]. Furthermore, a GST-fusion protein of the
cytoplasmic domain of YscU was found in the cytoplasm
not associated with the T3S apparatus, but was still able
to block secretion [73]. These results suggest a role for
YscU in the recruitment of ATPase complexes to the T3S
apparatus in order to initiate secretion. Similarly,
impassable GST fusions of YscP have been shown to
block secretion and co-purify with ATPase complexes
[73].
Needle length: the rod assembly model
There is little dispute that the Spa32 family of proteins is
responsible for needle-length control and substrate
switching. However, as brieﬂy mentioned earlier, there is
some disagreement in the literature about its role as a ruler/
tape measure. Alternative models for needle-length control
have been proposed in both pathogenic and ﬂagella T3SS
(reviewed in [55–58]). One model that we discuss here
involves a component known as the rod protein that is
thought to be the periplasmic portion of the needle. In
Salmonella, it has been shown that the needle-length pro-
tein, InvJ, is required for formation of the inner rod
structure, and reconstruction of a DinvJ needle complex
revealed signiﬁcant structural differences within the base
[74]. Although, InvJ is not detected as an integral com-
ponent of the base [11, 75], the DinvJ reconstruction
supports a role for InvJ in stabilisation of the socket and
inner rod structures. The model proposed by Marlovits
et al. suggests that completion of the inner rod anchors the
needle to the base and triggers a conformational change in
the base that switches substrate speciﬁcity.
Marlovits et al. also showed that altering the stoichi-
ometry of the inner rod and needle proteins has a profound
impact on the length of the needle substructure [74].
Recent work has shown that in Yersinia the rod protein,
YscI, plays a critical role in substrate speciﬁcity switching
[76]. Wood et al. suggest that YscP and YscU exert their
effects on substrate export by controlling the secretion of
YscI [76]. Together these observations support a role for
the rod protein in needle-length determination.
The abundance of data available relating to needle
length control in several species and in pathogenic and
non-pathogenic T3SS has allowed the proposal of many
different mechanisms for length control. It seems likely
that the fundamental mechanism of needle-length control
will be conserved across species, but at this stage these
models cannot yet be reconciled and in some cases appear
to be incompatible.
The second switch: assembly of the tip and late
substrate block
After completion of the needle structure, the tip complex is
assembled at the end of the needle, and the secretion of
effector proteins must be blocked. In Yersinia, a tip com-
plex has been visualised that is assembled at the tip of the
needle [77]. This complex is made up of several copies
of the protein LcrV and is present even in the absence of
effector secretion [77], suggesting that the secretion of
these two classes of substrates, tip protein and effectors, is
differently controlled.
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needle [78, 79], has been shown to interact directly with the
needle subunit, MxiH, in vitro [80], and is required for
the assembly of the translocators [81]. These data suggest
that the tip proteins are exported after the needle is
assembled but before the later substrates. In Shigella, the
translocator protein IpaB has also been identiﬁed at the
needle tip prior to membrane contact and without IpaC
recruitment [81–83]. Although the lack of detection of
IpaC may be due to technical limitations, these data sug-
gest that there is a stepwise secretion of the proteins that sit
at the tip of the needle. Whether there are distinct triggers
for the secretion of each of these components remains
uncertain. However, it is clear that the exact conditions
under which these experiments are conducted are critical in
determining which components are identiﬁed. For this
reason, there is some ambiguity about whether the trans-
locator proteins are a distinct secretion category from both
the tip proteins and the late effectors.
The transition from blockage to activation of effector
secretion can be considered the second switch of the T3SS
(Fig. 1c, d). A family of proteins, of which MxiC is the
Shigella homologue, has been identiﬁed that act as regu-
lators at this stage. Functional knockouts of members of
this family have no effect on needle formation or stability,
but do result in enhanced secretion of effector proteins
[17–19, 84, 85]. It has been proposed that these proteins
play an active role in repressing the secretion of effectors
and that they may function by interacting with the T3SS
apparatus in a manner that blocks secretion [84, 86]. In
support of this hypothesis, Botteaux et al. recently identi-
ﬁed an interaction between MxiC and the ATPase, Spa47
[17].
The Yersinia homologue of MxiC differs from that of
other species in that it exists as two separate polypeptide
chains: YopN and TyeA [87]. However, the structure of the
YopN–TyeA complex is very similar to that of the S. ﬂex-
neri homologue MxiC (Fig. 3a) [88, 89]. The structures
reveal that these proteins are rod-shaped with a highly
disordered N-terminus that possesses the secretion signal
and chaperone-binding region [90]. The rod shape provides
these proteins with a large surface area potentially allowing
for simultaneous interactions with several partner proteins.
Despite their similar fold, consisting of multiple bundles of
a-helices, these proteins possess almost no sequence con-
servation on their surfaces, suggesting that the sequences of
the proteins they interact with are also not highly con-
served. Interestingly, the overall shape of these two
structures is quite different due to twisting of some
domains and the kinking of a long, central helix (Fig. 3a).
Speciﬁcally, YopN–TyeA has a more curved shape,
whereas MxiC is quite straight. The conditions in which the
crystals of these proteins grew had very different pH
values: MxiC crystals were grown at pH 6.5–7.5, whereas
YopN–TyeA crystals grew at pH 10.5. Whether the dif-
ferences in these structures provide a glimpse of a
functionally important, potentially pH-dependent, confor-
mational change or whether they are artefacts of
crystallisation will require further study.
The structure of YopN in complex with its heterodi-
meric chaperone, SycN–YscB, has also been determined
(Fig. 3b) [89]. Although homologues have been identiﬁed
for most other chaperones within the T3SS, the homo-
logues of SycN and YscB have not yet been clearly
identiﬁed in other species. The binding faces for TyeA and
the chaperone complex lie at opposite ends of YopN and
are structurally independent. This observation suggests that
the different functions this family of proteins possess may
be structurally separated. Indeed, recent work with the
E. coli homologue, SepL, has demonstrated that its
Fig. 3 Structures of YopN complexes and MxiC. a Surface repre-
sentations (wheat) and ribbon diagrams of: YopN (blue) in complex
with TyeA (cyan) and MxiC (green). The central helix discussed in
the text is displayed as a cylinder. b Ribbon diagram of the complex
formed by YopN (blue), TyeA (cyan) and the chaperones SycN (pink)
and YscB (yellow). The N- and C-terminal residues of YopN are
highlighted (balls), and an unstructured region of YopN is displayed
as a dashed line
Regulation of type III secretion 1071different functions, including membrane localisation,
translocator export and effector secretion regulation, can be
separated [91].
The effects of knockouts in this family on tip and
translocator secretion seem to differ between species. In
E. coli and Salmonella, knockout of SepL or InvE,
respectively, reduce or abolish the secretion of the tip
protein and translocators [19, 20, 84, 92]. This phenotype is
similar to that observed for the N263A mutant of YscU,
namely the absence of tip and translocator secretion while
retaining the ability to secrete effector proteins. However,
an understanding of whether there is some co-ordination
between the ﬁrst and second switches in these species will
require further study.
The secretion of tip and translocator proteins is not
affected in Shigella and Yersinia strains knocked out for
MxiC and YopN, respectively [17, 65, 93]. However, these
strains are impaired in cell invasion and do not efﬁciently
translocate effectors. YopN is secreted by the T3SS, and it
has been suggested that TyeA suppresses the secretion of
YopN prior to host-cell contact. The dissociation of YopN
and TyeA has been proposed as a mechanism for the reg-
ulation of secretion, but clearly this cannot be a conserved
mechanism in those species where the homologue is a
single polypeptide chain [94, 95]. However, recently it has
been shown that in Shigella, MxiC is secreted and that its
secretion is required for its function [17]. In other species,
secretion of this component has not been seen.
In E. coli, it has been suggested that SepL and its
binding partner SepD control a switch from translocator to
effector secretion by sensing certain environmental signals
such as low calcium [84]. Similarly, in Yersinia, changes in
the environmental calcium concentration are thought to
relieve the TyeA-mediated blockage, triggering the secre-
tion of YopN and activating secretion [96–98]. This
response to low calcium levels is thought to involve both
the YopN–TyeA complex and a pathway involving the
negative regulator, LcrG, and its interaction with the tip
protein, LcrV [99, 100]. Recently, LcrG has also been
implicated in the negative regulation of transcription of
T3SS genes [101]. The indirect role played by LcrG
in transcriptional regulation is similar to that seen by
Botteaux et al. in a MxiC mutant that showed increased
expression of effector genes due to the increased secretion
of the anti-activator OspD1 [17, 102]. The secretion of
regulatory proteins is a convenient mechanism to control
their levels in the cell and provides one means of
co-ordinating secretion and switching. In ﬂagella, this has
been well studied for the regulatory protein FlgM
(reviewed in [27]). In addition, there is evidence that post-
transcriptional cleavage of transcripts plays a role in the
regulation of protein production [103]. The mechanisms of
this regulation are only beginning to be understood.
The data currently available for the regulation of type III
secretion do not support any single model for each step. It
is likely that there are subtle differences between species
due to varying numbers and types of proteins present in the
virulence repertoires of different species. Furthermore, the
ﬁnal trigger for effector secretion is likely to be unique to
each species due to their different host speciﬁcities and
local environments at infection.
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